Equities analysts predict that Henry Schein, Inc. (NASDAQ:HSIC) will post earnings of $1.11 per share for the current quarter, Zacks reports. Eight analysts have issued estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $1.08 and the highest estimate coming in at $1.14. Henry Schein reported earnings of $0.97 per share during the same quarter last year, which indicates a positive year over year growth rate of 14.4%. The firm is scheduled to issue its next earnings report before the market opens on Wednesday, February 20th.
According to Zacks, analysts expect that Henry Schein will report full year earnings of $4.12 per share for the current year, with EPS estimates ranging from $4.10 to $4.16. For the next year, analysts anticipate that the company will post earnings of $4.32 per share, with EPS estimates ranging from $3.64 to $4.55. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Henry Schein.
Get Henry Schein alerts:HSIC has been the topic of a number of recent analyst reports. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Thursday, January 24th. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday. Piper Jaffray Companies reiterated an “overweight” rating and set a $96.00 price target on shares of Henry Schein in a research report on Thursday, November 29th. ValuEngine upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. Finally, Royal Bank of Canada dropped their price target on shares of Henry Schein to $69.00 and set a “sector perform” rating for the company in a research report on Tuesday, February 12th. Seven research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the stock. Henry Schein currently has an average rating of “Hold” and an average target price of $83.69.
NASDAQ HSIC traded up $0.02 on Tuesday, reaching $62.39. The company had a trading volume of 2,440,314 shares, compared to its average volume of 1,979,813. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.70 and a current ratio of 1.30. The company has a market cap of $9.51 billion, a P/E ratio of 17.33, a P/E/G ratio of 1.84 and a beta of 0.89. Henry Schein has a 12 month low of $57.78 and a 12 month high of $91.35.
Henry Schein declared that its Board of Directors has authorized a share repurchase plan on Thursday, December 13th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.
In related news, CFO Steven Paladino sold 21,110 shares of Henry Schein stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $90.06, for a total value of $1,901,166.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stanley M. Bergman sold 69,000 shares of Henry Schein stock in a transaction that occurred on Friday, December 7th. The shares were sold at an average price of $86.32, for a total transaction of $5,956,080.00. Following the completion of the transaction, the chief executive officer now owns 240,096 shares of the company’s stock, valued at approximately $20,725,086.72. The disclosure for this sale can be found here. Insiders sold 105,856 shares of company stock valued at $9,222,275 in the last 90 days. Company insiders own 1.15% of the company’s stock.
Several hedge funds have recently made changes to their positions in HSIC. FMR LLC grew its stake in shares of Henry Schein by 167.3% during the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after buying an additional 4,151,179 shares during the last quarter. DNB Asset Management AS boosted its holdings in shares of Henry Schein by 8.3% during the third quarter. DNB Asset Management AS now owns 30,979 shares of the company’s stock worth $2,634,000 after purchasing an additional 2,373 shares during the period. Bank of Montreal Can boosted its holdings in shares of Henry Schein by 12.4% during the third quarter. Bank of Montreal Can now owns 415,759 shares of the company’s stock worth $35,352,000 after purchasing an additional 46,006 shares during the period. Bartlett & Co. LLC boosted its holdings in shares of Henry Schein by 53.9% during the third quarter. Bartlett & Co. LLC now owns 2,570 shares of the company’s stock worth $219,000 after purchasing an additional 900 shares during the period. Finally, Tandem Investment Advisors Inc. purchased a new stake in shares of Henry Schein during the third quarter worth about $229,000.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Return on Equity (ROE)
Get a free copy of the Zacks research report on Henry Schein (HSIC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment